Table 4.
Overall (n = 91) | CRP < 9.8 mg/L (n = 25) | CRP > 9.8 mg/L (n = 66) | p | |||
---|---|---|---|---|---|---|
N | % | N | % | |||
Age | 0.641 | |||||
≤ 55 | 48 | 12 | 25 | 36 | 75 | |
> 55 | 43 | 13 | 30 | 30 | 70 | |
Histopathologic differentiation | 0.721 | |||||
Poor | 25 | 6 | 24 | 19 | 76 | |
Moderate | 34 | 11 | 32 | 23 | 68 | |
Good | 32 | 8 | 25 | 24 | 75 | |
FIGO stage | < 0.05*1 | |||||
I | 23 | 4 | 17 | 19 | 83 | |
II | 29 | 4 | 14 | 25 | 86 | |
III | 18 | 8 | 44 | 10 | 56 | |
IV | 21 | 9 | 43 | 12 | 57 | |
Histologic type | 0.991 | |||||
Serous | 42 | 11 | 26 | 31 | 74 | |
Mucinous | 25 | 7 | 28 | 18 | 72 | |
Endometrioid | 17 | 5 | 29 | 12 | 71 | |
Clear cell | 7 | 2 | 28 | 5 | 72 | |
Tumor size | < 0.05*1 | |||||
≤ 5 cm | 38 | 5 | 13 | 33 | 87 | |
5–10 cm | 46 | 18 | 39 | 28 | 61 | |
> 10 cm | 7 | 2 | 28 | 5 | 72 |
Results showed that among these clinical correlations, high levels of CRP were significantly correlated with tumor size and pathologic staging. No significant correlation was found between CRP or other clinical parameters. Values of *p < 0.05 were considered statistically significant.
1Chi-squared test.